Gilead FCA Suit Satisfies Escobar, 9th Circ. Rules

The Ninth Circuit on Friday resurrected a multibillion-dollar False Claims Act suit accusing Gilead Sciences Inc. of defrauding taxpayers by concealing information about drug suppliers and contamination, saying the whistleblower suit...

Already a subscriber? Click here to view full article